Latest News & Features
Refine Search
Americas
Medtech company wins reversal of earlier ruling | Door opens to mount a challenge of controversial rule | USPTO director‘s updated guidelines influence court’s reasoning. 14 March 2023
Biotechnology
“Customer suit exception” is rejected by district judge | Suit between Chr. Hansen and Glycosyn is ongoing. 14 March 2023
Big Pharma
Sanofi and Regeneron accused of wanting to change patent system | The US Supreme Court will decide whether a controversial court decision should stand. 9 March 2023
Big Pharma
The University of Minnesota had raised three key issues on appeal | Sovereign immunity was at the heart of the years-long dispute. 7 March 2023
Big Pharma
The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri. 7 March 2023
Big Pharma
Health-related patents fell during 2022 against a backdrop of record global patents filed | Biotechnology was fastest growing field among Patent Cooperation Treaty applications | COVID-19 pandemic caused large falls in goods classes such as pharmaceuticals. 2 March 2023
Biotechnology
Boehringer Ingelheim challenged university patent | Board must provide more details on ruling. 2 March 2023
article
Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets. 28 February 2023
article
The move marks the firm’s second western merger this year | Joining firm has a strong presence in Denver and Asia markets. 28 February 2023
Big Pharma
Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel. 28 February 2023